SpletOur Solution From product development to distribution, we’re remaking partnerships to ensure today’s therapeutic innovations are more accessible and priced fairly. We are supporting healthcare systems in their urgency for new solutions. Our Model Our Model Collaborating to create change Our Leaders Splet01. feb. 2024 · TrademarkElite is the U.S. #1 Trademark Search and Registration Service :: TMALIN is a trademark and brand of MediLink Therapeutics(Suzhou)Co.,Ltd., Suzhou, …

EQRx

Splet01. mar. 2024 · Suzhou Medilink Therapeutics, an antibody-drug conjugate startup, closed a $50 million Series A financing. The financing includes a Series-A1 round led by Apricot … Splet14. mar. 2024 · MediLink Therapeutics (Suzhou) Co., Ltd (MediLink) recently announced completion of a US$70 million Series B financing. This round was led by LYFE Capital and Qiming Venture Partners, and co-invested by Legend Capital, Loyal Valley Capital and Highlight Capital (HLC), etc. The new funding will support clinical development of … dave gomes

Antibody-drug Conjugates Market is Predicted to Exhibit …

Splet14. mar. 2024 · SUZHOU, China, March 14, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd (MediLink) recently announced completion of a US$70 million Series B … SpletMediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast … SpletMediar Therapeutics: $85m Series A Led by NVF & Sofinnova; Avilar Tx Increases Seed Financing by $15m to $75m; Waters to Acquire Wyatt Technology for $1.36b in Cash; … baust khulna